TNF and bacterial infectious disease: Regarding the occurrence of severe bacterial infections, the adjusted HR was 0.69, 95% CI = 0.50; 0.95, p = 0.02 for patients receiving anti-TNFα, as shown in Figure 4A, and Supplementary Tables S4, S5.